Neutrophil‐Lymphocyte Ratio May be Used as a Biomarker for Predicting Progression of Barrett's Esophagus to Esophageal Adenocarcinoma: A Retrospective Cohort Study

Bibliographic Details
Title: Neutrophil‐Lymphocyte Ratio May be Used as a Biomarker for Predicting Progression of Barrett's Esophagus to Esophageal Adenocarcinoma: A Retrospective Cohort Study
Authors: Zarian Prenatt, Het Patel, Naomi Reddy‐Patel, Janak Bahirwani, Parampreet Kaur, Yecheskel Schneider
Source: JGH Open, Vol 9, Iss 3, Pp n/a-n/a (2025)
Publisher Information: Wiley, 2025.
Publication Year: 2025
Collection: LCC:Diseases of the digestive system. Gastroenterology
Subject Terms: Barrett's esophagus, esophageal adenocarcinoma, neutrophil‐lymphocyte ratio, Diseases of the digestive system. Gastroenterology, RC799-869
More Details: ABSTRACT Aims This study aims to investigate the correlation between the neutrophil‐lymphocyte ratio (NLR) and advancing stages of Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC). Methods and Results A retrospective cohort of patients diagnosed with BE and EAC were analyzed. Cases were categorized into four groups according to their histological diagnosis: non‐dysplastic BE (NDBE), low‐grade dysplasia (LGD), high‐grade dysplasia (HGD), and EAC. The NLR was calculated from a complete blood cell count within 6 months prior to diagnosis. A total of 140 patients were analyzed with a mean age of 67. The majority of patients were male (78.6%) and Caucasian (96.4%). Of the total, 32 (22.9%) patients had NDBE, 20 (14.3%) had LGD, 20 (14.3%) had HGD, and 68 (48.6%) had EAC. There was a statistically significant difference in NLR scores across the histological diagnoses. The mean NLR rank scores were 48.22 for NDBE, 44.75 for LGD, 60.35 for HGD, and 91.54 for EAC. Post hoc tests confirmed significant differences in NLR between NDBE and EAC, as well as LGD and EAC. Conclusions The study supports the potential use of NLR as a biomarker for predicting histologic progression in BE to EAC. The NLR could serve as a useful adjunct to current surveillance strategies to help guide clinical decision‐making. Further research is necessary to validate these findings and determine the clinical utility of NLR as a predictor for dysplasia and neoplasia in BE patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2397-9070
Relation: https://doaj.org/toc/2397-9070
DOI: 10.1002/jgh3.70115
Access URL: https://doaj.org/article/30a92edc538e48c9855c8756c5eccaee
Accession Number: edsdoj.30a92edc538e48c9855c8756c5eccaee
Database: Directory of Open Access Journals
More Details
ISSN:23979070
DOI:10.1002/jgh3.70115
Published in:JGH Open
Language:English